Alkem Laboratories reports marginal rise in Q3 consolidated net profit

16 Feb 2026 Evaluate

Alkem Laboratories has reported results for third quarter ended December 31, 2025 (Q3FY26).

The company has reported 13.96% fall in its net profit at Rs 622.14 crore for the third quarter ended December 31, 2025 as compared to net profit of Rs 723.12 crore for the same quarter in the previous year. However, total income of the company increased by 6.79% at Rs 2,622.80 crore for Q3FY26 as compared to Rs 2,456.01 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported marginal rise in its net profit at Rs 636.02 crore for the third quarter ended December 31, 2025 as compared to Rs 625.82 crore for the same quarter in the previous year. The total income of the company increased by 11.90% at Rs 3,879.92 crore for Q3FY26 as compared to Rs 3,467.27 crore for the corresponding quarter previous year.

Alkem Laboratories Share Price

5480.30 78.75 (1.46%)
16-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1699.75
Dr. Reddys Lab 1269.30
Cipla 1355.80
Zydus Lifesciences 910.00
Lupin 2220.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×